Key Highlights
- Rocket Lab successfully executed its inaugural dedicated mission for the European Space Agency (ESA) on March 28.
- The launch, dubbed “Daughter Of The Stars,” delivered ESA’s “Celeste” payload into low Earth orbit at a 510 km altitude.
- This marked RKLB’s sixth orbital mission of 2026 and the 85th flight for the Electron launch vehicle.
- The space services company secured a record-breaking $190 million U.S. Department of War contract for 20 hypersonic test missions, elevating its total backlog beyond $2 billion.
- Analysts maintain a Moderate Buy rating on RKLB, with a consensus price target of $89.36, suggesting approximately 47% potential upside.
Rocket Lab achieved a significant milestone on Friday evening by completing its inaugural dedicated launch for the European Space Agency, deploying a duo of experimental navigation satellites from its New Zealand facility. The Electron launch vehicle departed from Launch Complex 1 at 10:14 p.m. New Zealand Time on March 28, transporting ESA’s “Celeste” payload to a low Earth orbit positioned at 510 kilometers altitude.
Designated “Daughter Of The Stars,” this mission represents Rocket Lab’s sixth orbital delivery of 2026 and the 85th successful deployment utilizing its proven Electron rocket system.
The dual-satellite payload will assess whether a low Earth orbit satellite network can effectively complement Europe’s existing Galileo navigation infrastructure, which currently functions from medium Earth orbit. This experimental mission aims to enhance positioning precision throughout Europe for critical applications spanning autonomous transportation, maritime operations, and emergency response systems.
The spacecraft were manufactured by two separate European industrial teams — one spearheaded by GMV based in Spain, and another led by Thales Alenia Space headquartered in France.
RKLB stock advanced approximately 2% during Monday’s premarket session following the mission announcement.
The equity has declined 13% since the start of the year, affected by widespread market volatility and escalating U.S.-Iran geopolitical tensions. Nevertheless, on a 12-month basis, the stock has surged an impressive 231%.
Major Defense Contract Bolsters Pipeline
Beyond this ESA achievement, Rocket Lab recently finalized a substantial $190 million agreement with the U.S. Department of War to conduct 20 hypersonic test missions utilizing its HASTE launch platform. This represents the company’s largest individual contract to date.
This defense agreement propelled Rocket Lab’s total contract backlog above the $2 billion threshold.
Throughout the remainder of 2026, the company maintains a robust manifest encompassing commercial Earth observation missions, classified national security deployments, international space agency contracts, and hypersonic technology demonstration flights.
Neutron Rocket Remains Key Catalyst
This operational tempo precedes the highly anticipated inaugural flight of Rocket Lab’s more substantial Neutron launch vehicle, currently scheduled for late 2026.
Neutron is engineered to address the medium-lift launch sector, focusing on reusable missions capable of delivering larger commercial and governmental payloads.
Analysts maintain a Moderate Buy consensus rating on RKLB, supported by nine Buy recommendations and four Hold ratings. The average analyst price target stands at $89.36 — indicating potential upside of approximately 47% from present trading levels.





